幂方 Family | 诚益生物宣布迈克尔·怀立博士加入科学顾问委员会

2020-05-25​
作者: 管理员
来源: 未知

上海诚益生物科技有限公司,一家专注于代谢和免疫领域新药创制的生物制药公司,于2020年5月21日宣布迈克尔·怀立博士加入其科学顾问委员会。


怀立博士在制药行业拥有30多年的经验,是业界公认的药物研发领导者。他在美国礼来公司工作期间,成功带领研发团队在多个治疗领域将候选化合物推进临床试验。怀立博士精耕全球首创药物研发,对不同的靶点家族、生化路径、化合物类型和药物作用机制有着广泛和深入的研究。此外,怀立博士还因其跨学科、文化和地域界限的导师精神而备受赞誉。怀立博士曾在犹他大学获得化学博士学位,并在哥伦比亚大学完成博士后培训。


我们很荣幸地欢迎怀立博士加入我们的科学顾问委员会,诚益生物首席执行官周敬业博士说,怀立博士出色的药物研发能力,以及他在职业发展和项目管理方面的经验,必将为我们年轻的团队带来巨大的帮助。


Michael R. Wiley Phd

        迈克尔·怀立 博士


Shanghai, China, May 21, 2020 –Eccogene, Inc., a research driven biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced today the addition of Michael R. Wiley, Ph.D., to its scientific advisory board.


Dr. Wiley earned his PhD in chemistry from University of Utah and finished postdoctoral training at Columbia University. He is a well-recognized drug discovery leader with 30 years of experience in the pharmaceutical industry. Most recently, he was Research Fellow at Eli Lilly and company. He has been a successful scientific leader to deliver multiple clinical candidates across diverse therapeutic areas. His expertise spans a wide range of target families, biochemical pathways, chemotypes and mechanisms of action. In addition, Dr. Wiley is also appreciated for his passion of sharing, coaching and mentoring people in the industry across diverse disciplines, cultures and geographies.


We are privileged to welcome Dr. Wiley to join our scientific advisory board, said Jingye Zhou, PhD, CEO of Eccogene. “Dr. Wiley’s outstanding drug hunting capabilities, as well as his experiences in career development and project management will certainly be very helpful for our young team.” 

关于诚益生物

诚益生物专注于代谢和免疫领域,深耕疾病生物学、药物化学和转化科学,针对临床亟需的疾病种类,为全球市场提供可转化的创新型治疗方案。


Eccogene is a biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally.  The company focuses on discovery and development of translational medicine in metabolism and immune-related diseases. Eccogene is specialized in disease biology, medicinal chemistry, and translational science to advance its growing pipeline of drugs.